Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Novamind Inc (NM.CN)

Novamind Inc (NM.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Novamind Inc 10 Wanless Avenue Suite 201 Toronto ON M4N 1V6 CAN

P: 647-953-9512

Description:

Novamind Inc is a mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. It has two reportable segments namely mental health clinics and corporate.

Key Statistics

Overview:

Market Capitalization, $K 14,168
Shares Outstanding, K 40,201
Annual Sales, $ 6,069 K
Annual Net Income, $ -7,254 K
Last Quarter Sales, $ 3,227 K
Last Quarter Net Income, $ -2,376 K
% of Institutional Shareholders 0.29%

Growth:

1-Year Return -77.48%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.24
EPS Growth vs. Prev Year -86.05%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NM.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -94.97%
Return-on-Assets % -61.05%
Profit Margin % -119.52
Net Margin % -1.17
Debt/Equity 0.56
Price/Sales 1.44
Price/Book 1.55
Book Value/Share 0.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar